In a landmark deal announced this month, President Donald Trump negotiated dramatically lower costs for weight-loss drugs ...
A 2026 CMS proposed rule contains multiple provisions that will improve the transparency of hospital prices and support the ...
The Centers for Medicare and Medicaid Services hosted health tech leaders at a Health Tech Ecosystem Connectathon event in Washington, D.C. | On Thursday, the Centers for Medicare and Medicaid ...
Key Takeaways - CMS maintains its authority to impose Medicare reenrollment bars: CMS emphasizes its ability to apply reenrollment ...
The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life ...
Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ...
Medicare will cover GLP-1 weight loss drugs for specific patient groups, beginning in mid-2026, under a deal struck with drugmakers.
The two-month reprieve extends through January 2026. While some providers are restarting telehealth services, it remains ...
Thousands of Americans die every year due to hospital mistakes. A patient safety nonprofit grades how well hospitals limit ...
Asheville Watchdog on MSN
“There’s no way”: Huge ACA premium hikes force Buncombe policyholders to make hard choices, including dropping coverage
Average payments for the policies will more than double, says an independent research group, and costs will be higher in WNC.
Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback